About Prilenia
Prilenia, a private biopharmaceutical company with a highly committed and talented global team, is seeking a Vice President of Clinical Operations located in the US.
Prilenia has a simple but urgent mission – to bring transformative medicines to people affected by devastating neurodegenerative diseases. Unwavering in our commitment to scientific excellence, Prilenia is developing pridopidine, a unique, oral, sigma-1 receptor (S1R) agonist investigational neuroprotective therapy for ALS and Huntington’s disease (HD). Partnered with Ferrer for the commercialization and co-development of pridopidine, we plan to start two key late-stage trials to support potential approval globally in ALS and in HD in the first half of 2026.
About the role
We are seeking a dynamic Executive Director, Clinical Operations to join our team and lead strategic execution of global pivotal trial/s in neurodegeneration. The ideal candidate will bring extensive experience in global clinical operations, with proven track record in managing global pivotal clinical trials for biotech sponsors, and a vision to innovate and continuously improve operational standards. Experience in rare diseases required, HD and/or ALS preferred. This is a critical leadership role in a growing biotech company, suitable for a candidate who is equally comfortable driving high-level strategy and rolling up their sleeves. The position will report to the SVP, Head of Clinical Operations.